Background: The aim of the study was to demonstrate the safety and effectiveness of a suture-mediated vascular closure device to perform hemostasis after an axillary artery access during endovascular procedures on the aortic valve, the aorta and its side branches.
Methods: A physician-initiated, international, multicenter, retrospective registry was designed to evaluate the success rate (VARC-2 reporting standards) of percutaneous transaxillary access closure with a suture-mediated closure device. Secondary end points were minor access vascular complications, transient peripheral nerve injury, stroke, and influence on periprocedural outcomes of puncture technique.
Results: Three hundred thirty-one patients (median age, 76 years; 69.2% males) in 11 centers received a percutaneous transaxillary access during endovascular cardiac (n = 166) or vascular (n = 165) procedures. The closure success rate was 84.6%, with 5 open conversions (1.5%), 45 adjunctive endovascular procedures (13.6%), and 1 nerve injury (0.3%). Secondary closure success was obtained in 325 patients (98%) after 7 bare stenting, 37 covered stenting, and 1 thrombin injection. Introducer sheaths 16F or larger (odds ratio, 3.70; 95% confidence interval, 1.22-11.42) and balloon-assisted hemostasis (odds ratio, 4.45; 95% confidence interval, 1.27-15.68) were associated with closure failure. A threshold of five percutaneous axillary accesses was associated with decreased rates of open conversion, but not with increased primary closure success. Primary closure success was 90.3% in the 175 patients with sheaths smaller than 16F, performed after the first 5 procedures in each center. Temporary nerve injury and stroke were observed in 2% and 4% of patients, respectively.
Conclusions: Percutaneous transaxillary aortic procedures, in selected patients, can be performed with low rates of open conversion. The need for additional endovascular bailout procedures is not negligible when introducers sheaths 16F or larger are required.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvs.2021.08.089 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Contemporary Outcomes of Degenerative Mitral Valve Surgery in a Regional Tertiary Care Center.
J Clin Med
November 2024
Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, 60121 Ancona, Italy.
Article Synopsis
- * Mitral valve repair was successful in 90.9% of cases, with posterior leaflet lesions showing the highest success rates, while the in-hospital mortality rate was low at 0.6%.
- * Results indicate that despite the emergence of less invasive techniques, surgical repair remains the best option for most DMR patients, with a 5-year survival rate of 95.5%.
Background: Endovascular treatment of peripheral arterial disease requires safe and reliable arterial access. This study evaluates the feasibility and safety of percutaneous axillary artery access for endovascular therapy. A variety of anatomic and logistic obstacles can be overcome with upper extremity access.
View Article and Find Full Text PDFAxillary compared to brachial access for endovascular procedures.
Vascular
August 2024
Division of Vascular and Interventional Radiology, Joint Department of Medical Imaging, Toronto, ON, Canada.
Article Synopsis
- The study aimed to compare complication rates at access sites for trans-axillary and trans-brachial approaches using sheath sizes of 6Fr or larger in endovascular interventions.
- A total of 67 cases were reviewed over 18 months, and the main outcome was the occurrence of major site complications within 30 days.
- Results showed no significant difference in complication rates between the trans-axillary (15%) and trans-brachial (17%) groups, indicating that both methods are safe, with trans-axillary being particularly effective for larger sheath sizes.
Alternative access in transcatheter aortic valve replacement-an updated focused review.
Front Cardiovasc Med
August 2024
Division of Cardiology, Department of Medicine, University of California Irvine Medical Center, Orange, California, CA, United States.
Aortic Stenosis (AS) is a common condition with an estimated pooled prevalence of all AS in the elderly population at around 12.4%, with that of severe AS estimated to be around 3.4%.
View Article and Find Full Text PDFThe role of the vascular surgeon in transcatheter aortic valve implantation.
Vascular
March 2024
Vascular Surgery, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Background: Transcatheter aortic valve implantation (TAVI) has become the standard treatment for severe aortic valve stenosis in patients at increased surgical risk. Percutaneous transfemoral (TF) is the access of choice due to its reduced invasiveness and perioperative morbidity/mortality compared with the trans-axillary, aortic, and apical routes. On the other hand, vascular access complications (VACs) of the TF access are associated with prolonged hospitalization, 30-day, and 1-year mortality.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!